Urine vs Blood vs Hair vs Saliva: Cannabis Test Types Compared

Urine: The Workhorse Strong evidence

Virtually every major athlete cannabis testing program uses urine as the primary matrix. The target analyte is 11-nor-9-carboxy-Δ&sup9;-tetrahydrocannabinol (THC-COOH), the inactive carboxy metabolite of THC. THC-COOH is biologically inactive but fat-soluble and persists in urine for days to weeks after exposure. The first stage of testing is a urine immunoassay screen — antibody-based, cheap, fast, and prone to cross-reactivity with structurally similar molecules. Any non-negative immunoassay screen is reflexed to a confirmatory test: gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS). Confirmatory testing identifies THC-COOH by molecular fingerprint and quantifies the concentration.

WADA-accredited laboratories apply both the 150 ng/mL Adverse Analytical Finding (AAF) threshold and the 180 ng/mL Decision Limit to absorb measurement uncertainty. The NFL uses 350 ng/mL since December 6, 2024. See Thresholds & Windows for the full league-by-league number.

Blood: Current Intoxication, Poor Impairment Proxy

Blood testing measures parent THC, not the metabolite. Parent THC is what produces the acute high, but it falls quickly in plasma after exposure — hours, occasionally up to two days in heavy chronic users. Blood is therefore the best matrix for documenting recent exposure but is not used as a routine athlete-screening tool.

The bigger problem is impairment correlation. The U.S. Department of Transportation Report to Congress on Marijuana-Impaired Driving (July 2017) concluded that "a quantitative threshold for per se laws for THC following cannabis use cannot be scientifically supported." THC's distribution between blood and tissue is fast and non-linear: a heavy chronic user can have measurable blood THC long after any acute effect has resolved, while an occasional user can be most impaired at relatively low blood concentrations. That is why state athletic commissions experimenting with impairment-only enforcement (Nevada from July 2021; Florida from May 2021) tend to use observed-impairment evaluations rather than fixed blood-THC thresholds.

Oral Fluid (Saliva): The "Better Recency Proxy" That Hasn't Been Adopted

Saliva testing detects parent THC at the oral mucosa for roughly 24 hours after use. The detection window is narrower than urine and roughly aligns with the period of most likely psychoactive effect — which makes oral fluid a more attractive proxy for "current impairment" than urinary THC-COOH. Some employer-side drug-testing companies have moved toward oral fluid for that reason.

Despite the theoretical fit, no major league has adopted oral fluid testing for cannabis as of May 2026. The primary holdup is calibration: oral fluid thresholds tied to functional impairment have not been agreed across the anti-doping community, and WADA's accredited-laboratory infrastructure is built around urine. Athletes encountering oral fluid testing typically do so in employment contexts, not in regulated competition.

Hair: ~90-Day Cumulative Exposure

Hair testing extracts cannabinoids deposited into the hair shaft as it grows. Because head hair grows roughly 1 cm per month, a 3 cm sample captures a window of approximately 90 days. Hair is used by some employers and in forensic settings, and increasingly in custody and probation contexts. It is rarely used by major sports leagues for cannabis, in part because the long detection window catches use that has nothing to do with current performance and in part because hair-testing protocols for cannabinoids are more variable than urine. The 2020 NFL CBA narrowed testing to a roughly two-week training-camp window precisely to move away from the broad detection windows hair would extend further.

The Labs Behind UFC and Olympic Testing

For elite-level testing, the laboratory matters as much as the matrix. WADA-accredited laboratories run Olympic and USADA samples under standardized methods. Within combat sports specifically, the Sports Medicine Research and Testing Laboratory (SMRTL) in Salt Lake City has been the analytical lab for UFC under the Combat Sports Anti-Doping (CSAD) framework that took over from USADA on January 1, 2024. Drug Free Sport International (DFSI) handles sample collection. Olympic-eligible UFC athletes additionally fall under USADA's WADA-aligned program.

The most consequential lab-versus-lab episode in modern combat-sports cannabis testing is the Nick Diaz case around UFC 183 (January 31, 2015). Diaz produced three samples that day: two were analyzed by SMRTL and returned negative for cannabis metabolites; one was analyzed by Quest Diagnostics and returned positive. The Nevada State Athletic Commission imposed a 5-year suspension and $165,000 fine on September 14, 2015 (the second-longest suspension in NSAC history), reduced to 18 months and $100,000 in a 2016 settlement. The discrepancy between two accredited labs analyzing samples from the same fighter on the same night galvanized advocates of cannabis-policy reform in athletic-commission frameworks. NSAC stopped punishing fighters for cannabis use in July 2021.

Which Matrix Applies to You

For practical purposes:

• If you compete under WADA, USADA, MLS, or pre-2024 NCAA championship rules, expect urine THC-COOH testing in-competition at 150 ng/mL.
• If you compete in the NFL, expect urine THC-COOH testing at 350 ng/mL during the ~2-week training-camp window.
• If you face an impairment evaluation at a state athletic commission, observed impairment plus possibly blood or oral fluid may apply — rather than an automatic THC-COOH threshold.
• If you face employer-side testing as part of a college-athletics or league-affiliated job (training-staff, league employee, etc.), urine immunoassay (often at lower thresholds than the league applies to athletes) or oral fluid is most likely.

For threshold mechanics see Thresholds & Windows; for in/out-of-comp definitions see In-Competition vs Out-of-Competition; for washout planning see Washout Protocols.